Group Objectives
The Biotechnology group focuses on cutting edge
research addressing crucial regional challenges with broad
international impact. The group utilizes contemporary molecular and
genomic approaches to address important biomedical challenges. In
addition to the well-established Yousef Jameel Biotechnology Laboratory,
which is equipped with state-of-the-art equipment in the field of
molecular and cell biology, the group also counts on the latest
contemporary genomics facility, including a high-throughput Genome
Analyzer sequencing system and high performance computational facility.
Our goal focuses on utilizing fundamental scientific research to develop
diverse applications in the biotechnological field.
Research Activities and Interests
Biotechnology Group focuses on researches related to:
- Genomic approaches to the
production of alternative energy.
- Regional
molecular characterization of Influenza virus for effective vaccine
design
- Environmental genomic of
the Nile river and the Red Sea.
- Transcription
regulation of tumor suppressor genes in selected cancer
- Gene therapy design application for HCV genome
- HCV docking for novel drugs
- Endemic diseases in Egypt like Bilharzias, Fascioliasis
and liver cancer
Collaborations
The Biotechnology group is conducting
research work in collaboration with national
institutions such as:
- The National Research Center (NRC)
- The US-Naval Medical Research Unit (NAMRU-3)
- Theodor Bilharz Research Institute
- National Hepatology and Tropical Medicine Research
Institute
- Information Technology
Institute
and international
institutions as
- Virginia Tech,
(USA)
- McGill University, Canada,
- United States Department of
Agriculture
- University of São
Paulo, Brazil
- Institute of
Pathology, Jena University, Germany
- Italian Institute of Health “Istituto Superiore di
Sanita” , Rome, Italy
Members
- Dr.
Hamza El Dorry
- Dr.
Rania Siam
- Dr.
Suher Zada
|
|
|